Latest Global Markets News

Dimerix has acquired DMX-652, a Phase 2-ready oral drug candidate targeting acute kidney injury, expanding its renal disease portfolio. The acquisition includes patent rights, an FDA-approved trial protocol, and funding to initiate clinical development.

Advanced Engineered Materials has locked in an exclusive supply agreement with Swiss manufacturer Zürcher Frères, leveraging its nano particle high purity alumina to significantly enhance zirconia-alumina ceramics used in medical and industrial applications.

ABx Group’s ALCORE subsidiary has begun civil construction at its Bell Bay pilot plant, advancing a novel process to produce hydrogen fluoride from aluminium smelter by-products, addressing Australia’s dependence on imports.

WCM Global Growth Limited delivered a stellar 19.28% return in the June quarter, outpacing its MSCI benchmark, while announcing a series of progressive fully franked dividends through FY2027.

OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.

EcoGraf has appointed Sven Olsson as an independent director and Peter Schuhmacher as a board advisor to bolster its European investor relations and advance its HFfree purification technology amid growing ESG demand.

White Energy confirms ASX listing rules exemption for its proposed US metallurgical and Surat Basin coal assets acquisition, advancing due diligence and capital raising plans.

Identitii has secured a $20 million convertible note facility with The Blackstone Mercantile Group, including a $5 million binding commitment subject to shareholder approval. The funding aims to support growth of the BNDRY platform and strengthen the company’s balance sheet ahead of a planned cashflow breakeven.

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

ClearVue Technologies has earned three international certifications for its Gen 3 Vision Glass, confirming its photovoltaic performance, safety, and durability across multiple product variants.

WhiteHawk has locked in A$685,000 from customer renewals and program expansions, reinforcing its foothold in cybersecurity across financial services, education, and government sectors.

EQ Resources Ltd is set to boost its tungsten footprint in Far North Queensland by acquiring Aus Critical Minerals and TTTP1, increasing its Mt Carbine tenure by 45% to 1,136 square kilometres.